25 XP   0   0   10

Quantrx Biomedical
Buy, Hold or Sell?

Let's analyse Quantrx together

PenkeI guess you are interested in Quantrx Biomedical. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Quantrx Biomedical. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Quantrx Biomedical

I send you an email if I find something interesting about Quantrx Biomedical.

Quick analysis of Quantrx (30 sec.)










What can you expect buying and holding a share of Quantrx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-0.04
Expected worth in 1 year
$-0.04
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-82.8%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.004 - $0.004
How sure are you?
50%

1. Valuation of Quantrx (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$0.00 - $0.02

Total Value Per Share

$-0.04 - $-0.01

2. Growth of Quantrx (5 min.)




Is Quantrx growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.8m-$2.4m-$260.7k-9.6%

How much money is Quantrx making?

Current yearPrevious yearGrowGrow %
Making money-$66k-$66.7k769.001.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Quantrx (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

What can you expect buying and holding a share of Quantrx? (5 min.)

Welcome investor! Quantrx's management wants to use your money to grow the business. In return you get a share of Quantrx.

What can you expect buying and holding a share of Quantrx?

First you should know what it really means to hold a share of Quantrx. And how you can make/lose money.

Speculation

The Price per Share of Quantrx is $0.004. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Quantrx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Quantrx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.04. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Quantrx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-19.4%0.00-20.7%0.00-20.9%0.00-15.1%0.00-27.1%
Usd Book Value Change Per Share0.00-19.4%0.00-20.7%0.00-20.9%0.00-14.6%0.00-21.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-19.4%0.00-20.7%0.00-20.9%0.00-14.6%0.00-21.1%
Usd Price Per Share0.01-0.01-0.01-0.01-0.02-
Price to Earnings Ratio-1.83--2.15--3.70--1.62--2.88-
Price-to-Total Gains Ratio-7.33--7.94--10.71--5.22-13.94-
Price to Book Ratio-0.16--0.20--0.39--0.25--1.51-
Price-to-Total Gains Ratio-7.33--7.94--10.71--5.22-13.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.004
Number of shares250000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (250000 shares)-206.89-146.03
Gains per Year (250000 shares)-827.57-584.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-828-8380-584-594
20-1655-16660-1168-1178
30-2483-24940-1752-1762
40-3310-33220-2336-2346
50-4138-41500-2921-2930
60-4965-49780-3505-3514
70-5793-58060-4089-4098
80-6621-66340-4673-4682
90-7448-74620-5257-5266
100-8276-82900-5841-5850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%2.037.01.05.0%10.095.04.09.2%
Book Value Change Per Share0.03.01.00.0%0.09.03.00.0%2.013.05.010.0%4.027.09.010.0%26.068.015.023.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.0108.00.9%
Total Gains per Share0.03.01.00.0%0.09.03.00.0%2.013.05.010.0%4.027.09.010.0%26.068.015.023.9%

Fundamentals of Quantrx

About Quantrx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Fundamental data was last updated by Penke on 2024-04-24 17:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Quantrx Biomedical.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Quantrx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-8,957.9%+8,957.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-6.2%
TTM-6.2%-6.2%
YOY-8.0%-8.0%
5Y-7.3%-7.3%
10Y-8,957.9%6.8%-8,964.7%
1.1.2. Return on Assets

Shows how efficient Quantrx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • -1,136.3% Return on Assets means that Quantrx generated $-11.36 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Quantrx Biomedical:

  • The MRQ is -1,136.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1,232.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,136.3%TTM-1,232.1%+95.8%
TTM-1,232.1%YOY-201.5%-1,030.5%
TTM-1,232.1%5Y-323.2%-908.9%
5Y-323.2%10Y-179.4%-143.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,136.3%1.3%-1,137.6%
TTM-1,232.1%1.4%-1,233.5%
YOY-201.5%1.9%-203.4%
5Y-323.2%2.2%-325.4%
10Y-179.4%2.0%-181.4%
1.1.3. Return on Equity

Shows how efficient Quantrx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • 0.0% Return on Equity means Quantrx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-2.6%
TTM-2.8%-2.8%
YOY-3.7%-3.7%
5Y-3.9%-3.9%
10Y-3.9%-3.9%

1.2. Operating Efficiency of Quantrx Biomedical.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Quantrx is operating .

  • Measures how much profit Quantrx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Quantrx Biomedical:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-6,476.3%+6,476.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-7.6%-7.6%
YOY-10.9%-10.9%
5Y-10.1%-10.1%
10Y-6,476.3%10.5%-6,486.8%
1.2.2. Operating Ratio

Measures how efficient Quantrx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y65.404-65.404
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.153-1.153
TTM-1.168-1.168
YOY-1.105-1.105
5Y-1.097-1.097
10Y65.4041.056+64.348

1.3. Liquidity of Quantrx Biomedical.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Quantrx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.002. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.002. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.0020.000
TTM0.002YOY0.016-0.014
TTM0.0025Y0.111-0.109
5Y0.11110Y0.115-0.004
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0022.302-2.300
TTM0.0022.333-2.331
YOY0.0162.588-2.572
5Y0.1112.627-2.516
10Y0.1152.623-2.508
1.3.2. Quick Ratio

Measures if Quantrx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.001+0.000
TTM0.001YOY0.016-0.015
TTM0.0015Y0.125-0.124
5Y0.12510Y0.110+0.015
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0011.098-1.097
TTM0.0011.127-1.126
YOY0.0161.306-1.290
5Y0.1251.430-1.305
10Y0.1101.533-1.423

1.4. Solvency of Quantrx Biomedical.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Quantrx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Quantrx to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 528.69 means that Quantrx assets are financed with 52,869.2% credit (debt) and the remaining percentage (100% - 52,869.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Quantrx Biomedical:

  • The MRQ is 528.692. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 504.487. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ528.692TTM504.487+24.205
TTM504.487YOY75.791+428.696
TTM504.4875Y122.278+382.209
5Y122.27810Y63.595+58.682
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ528.6920.357+528.335
TTM504.4870.360+504.127
YOY75.7910.353+75.438
5Y122.2780.365+121.913
10Y63.5950.371+63.224
1.4.2. Debt to Equity Ratio

Measures if Quantrx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Quantrx Biomedical:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.541-0.541
TTM-0.561-0.561
YOY-0.551-0.551
5Y-0.653-0.653
10Y-0.669-0.669

2. Market Valuation of Quantrx Biomedical

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Quantrx generates.

  • Above 15 is considered overpriced but always compare Quantrx to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -1.83 means the investor is paying $-1.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Quantrx Biomedical:

  • The EOD is -1.287. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.833. Based on the earnings, the company is expensive. -2
  • The TTM is -2.152. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.287MRQ-1.833+0.547
MRQ-1.833TTM-2.152+0.319
TTM-2.152YOY-3.704+1.552
TTM-2.1525Y-1.624-0.529
5Y-1.62410Y-2.883+1.259
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-1.28714.408-15.695
MRQ-1.83315.934-17.767
TTM-2.15216.376-18.528
YOY-3.70422.147-25.851
5Y-1.62420.830-22.454
10Y-2.88325.069-27.952
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Quantrx Biomedical:

  • The EOD is -20.919. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -29.809. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.690. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.919MRQ-29.809+8.890
MRQ-29.809TTM-13.690-16.120
TTM-13.690YOY-31.692+18.002
TTM-13.6905Y-10.241-3.448
5Y-10.24110Y-11.679+1.438
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-20.9199.511-30.430
MRQ-29.8099.241-39.050
TTM-13.6900.922-14.612
YOY-31.6923.453-35.145
5Y-10.2415.897-16.138
10Y-11.679-0.177-11.502
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Quantrx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of -0.16 means the investor is paying $-0.16 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Quantrx Biomedical:

  • The EOD is -0.111. Based on the equity, the company is expensive. -2
  • The MRQ is -0.158. Based on the equity, the company is expensive. -2
  • The TTM is -0.203. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.111MRQ-0.158+0.047
MRQ-0.158TTM-0.203+0.045
TTM-0.203YOY-0.389+0.186
TTM-0.2035Y-0.255+0.052
5Y-0.25510Y-1.509+1.255
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1112.448-2.559
MRQ-0.1582.753-2.911
TTM-0.2032.691-2.894
YOY-0.3893.294-3.683
5Y-0.2553.563-3.818
10Y-1.5094.227-5.736
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Quantrx Biomedical compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001+6%-0.001+7%-0.001-25%-0.001+9%
Book Value Per Share---0.036-0.035-4%-0.031-13%-0.025-30%-0.020-45%
Current Ratio--0.0020.002-6%0.016-88%0.111-98%0.115-98%
Debt To Asset Ratio--528.692504.487+5%75.791+598%122.278+332%63.595+731%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.001-0.001+6%-0.001+7%-0.001-22%-0.001+40%
Free Cash Flow Per Share--0.0000.000+320%0.000+160%0.000+882%-0.001+975%
Free Cash Flow To Equity Per Share--0.0000.000-50%0.000+258%0.000+1546%0.000+323%
Gross Profit Margin--1.0001.065-6%1.012-1%1.036-3%1.032-3%
Intrinsic Value_10Y_max--0.023--------
Intrinsic Value_10Y_min--0.001--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.002--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min---0.004--------
Intrinsic Value_5Y_max--0.005--------
Intrinsic Value_5Y_min---0.004--------
Market Cap314785.984-43%448570.027548908.060-18%960097.251-53%497361.855-10%1386055.473-68%
Net Profit Margin----0%-0%-0%-89.5790%
Operating Margin----0%-0%-0%-64.7630%
Operating Ratio----0%-0%-0%65.404-100%
Pb Ratio-0.111+30%-0.158-0.203+28%-0.389+146%-0.255+61%-1.509+856%
Pe Ratio-1.287+30%-1.833-2.152+17%-3.704+102%-1.624-11%-2.883+57%
Price Per Share0.004-43%0.0060.007-18%0.012-53%0.006-10%0.018-68%
Price To Free Cash Flow Ratio-20.919+30%-29.809-13.690-54%-31.692+6%-10.241-66%-11.679-61%
Price To Total Gains Ratio-5.146+30%-7.334-7.937+8%-10.706+46%-5.220-29%13.943-153%
Quick Ratio--0.0010.001+30%0.016-92%0.125-99%0.110-99%
Return On Assets---11.363-12.321+8%-2.015-82%-3.232-72%-1.794-84%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.001-0.001+6%-0.001+7%-0.001-25%-0.001+9%
Usd Book Value---2840565.000-2725539.500-4%-2464802.750-13%-1982115.000-30%-1576262.350-45%
Usd Book Value Change Per Share---0.001-0.001+6%-0.001+7%-0.001-25%-0.001+9%
Usd Book Value Per Share---0.036-0.035-4%-0.031-13%-0.025-30%-0.020-45%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.001-0.001+6%-0.001+7%-0.001-22%-0.001+40%
Usd Free Cash Flow---3762.000-15809.500+320%-9780.000+160%-36954.650+882%-39430.100+948%
Usd Free Cash Flow Per Share--0.0000.000+320%0.000+160%0.000+882%-0.001+975%
Usd Free Cash Flow To Equity Per Share--0.0000.000-50%0.000+258%0.000+1546%0.000+323%
Usd Market Cap314785.984-43%448570.027548908.060-18%960097.251-53%497361.855-10%1386055.473-68%
Usd Price Per Share0.004-43%0.0060.007-18%0.012-53%0.006-10%0.018-68%
Usd Profit---61166.000-66014.750+8%-66783.750+9%-20151.050-67%-75098.925+23%
Usd Revenue----0%-0%-0%-4474.4500%
Usd Total Gains Per Share---0.001-0.001+6%-0.001+7%-0.001-25%-0.001+9%
 EOD+2 -6MRQTTM+15 -13YOY+14 -145Y+8 -2010Y+15 -16

3.2. Fundamental Score

Let's check the fundamental score of Quantrx Biomedical based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.287
Price to Book Ratio (EOD)Between0-1-0.111
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.002
Debt to Asset Ratio (MRQ)Less than1528.692
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-11.363
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Quantrx Biomedical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.144
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.006
OpenGreater thanClose0.004
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5
Total Liabilities2,846
Total Stockholder Equity-2,841
 As reported
Total Liabilities 2,846
Total Stockholder Equity+ -2,841
Total Assets = 5

Assets

Total Assets5
Total Current Assets5
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 4
Other Current Assets 1
Total Current Assets  (as reported)5
Total Current Assets  (calculated)5
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,846
Long-term Liabilities2,846
Total Stockholder Equity-2,841
Total Current Liabilities
Short-term Debt 2,829
Short Long Term Debt 2,829
Accounts payable 16
Other Current Liabilities 16
Total Current Liabilities  (as reported)2,846
Total Current Liabilities  (calculated)5,692
+/- 2,846
Long-term Liabilities
Long-term Liabilities  (as reported)2,846
Long-term Liabilities  (calculated)0
+/- 2,846
Total Stockholder Equity
Common Stock787
Retained Earnings -52,574
Accumulated Other Comprehensive Income 9
Other Stockholders Equity 48,876
Total Stockholder Equity (as reported)-2,841
Total Stockholder Equity (calculated)-2,903
+/- 62
Other
Capital Stock849
Cash and Short Term Investments 4
Common Stock Shares Outstanding 78,696
Current Deferred Revenue-16
Liabilities and Stockholders Equity 5
Net Debt 2,826
Net Invested Capital -73
Net Tangible Assets -2,903
Net Working Capital -2,841
Short Long Term Debt Total 2,829



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312002-12-312002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-31
> Total Assets 
0
490
360
4,680
3,700
4,830
4,160
3,470
3,470
1,600
1,700
1,980
1,980
3,790
3,140
1,970
1,460
1,700
1,360
1,870
1,270
1,210
1,510
1,300
1,440
930
890
588
590
480
450
391
390
110
90
0
0
0
188
141
188
654
1,322
4,650
4,061
3,575
4,313
4,313
4,265
3,480
3,651
3,633
3,543
3,537
3,405
3,405
1,480
2,193
1,344
1,041
1,430
1,463
1,302
1,302
587
624
1,302
586
570
610
474
474
438
429
398
398
372
551
491
491
437
396
359
359
279
222
213
213
225
190
1,391
1,391
1,201
1,111
582
582
440
384
137
137
83
61
55
55
28
21
6
6
5
5
55662128555561831371373844405825821,1111,2011,3911,3911902252132132222793593593964374914915513723983984294384744746105705861,3026245871,3021,3021,4631,4301,0411,3442,1931,4803,4053,4053,5373,5433,6333,6513,4804,2654,3134,3133,5754,0614,6501,322654188141188000901103903914504805905888909301,4401,3001,5101,2101,2701,8701,3601,7001,4601,9703,1403,7901,9801,9801,7001,6003,4703,4704,1604,8303,7004,6803604900
   > Total Current Assets 
0
30
80
4,380
3,320
4,520
3,620
2,880
2,880
810
910
1,210
1,210
2,990
2,290
1,020
530
800
490
1,040
450
420
740
600
880
370
420
0
140
90
80
0
40
30
20
0
0
0
120
75
120
580
1,249
3,007
1,789
1,167
0
1,837
1,421
656
886
899
878
940
686
686
986
1,060
829
614
1,024
1,083
0
939
294
337
939
311
304
349
238
238
193
156
158
158
136
317
260
260
208
172
137
137
62
7
29
29
43
9
891
891
701
611
360
360
218
162
137
137
83
61
55
55
28
21
6
6
5
5
5566212855556183137137162218360360611701891891943292976213713717220826026031713615815815619323823834930431193933729493901,0831,0246148291,0609866866869408788998866561,4211,83701,1671,7893,0071,249580120751200002030400809014004203708806007404204501,0404908005301,0202,2902,9901,2101,2109108102,8802,8803,6204,5203,3204,38080300
       Cash And Cash Equivalents 
0
10
60
3,920
3,070
4,380
3,430
2,460
2,460
130
330
670
670
2,520
1,880
530
50
300
110
670
150
130
500
430
740
200
290
0
10
0
10
0
10
30
20
0
0
0
108
67
108
527
991
2,600
1,101
620
0
1,257
916
185
213
157
179
254
66
66
285
551
376
203
128
50
230
230
12
31
230
8
1
19
10
10
2
1
4
4
66
254
219
219
189
84
61
61
4
7
1
1
33
9
863
460
291
210
322
322
201
155
130
130
83
61
55
55
28
21
6
6
2
4
426621285555618313013015520132232221029146086393311746161841892192192546644121010191823031122302305012820337655128566662541791572131859161,25706201,1012,600991527108671080002030100100100290200740430500130150670110300505301,8802,5206706703301302,4602,4603,4304,3803,0703,92060100
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
403
403
401
401
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000401401403403000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
30
30
0
150
10
40
30
30
30
30
60
80
120
50
40
30
40
20
20
10
50
10
0
30
20
20
0
20
0
0
0
0
0
0
0
0
0
0
4
203
207
0
461
361
372
296
329
287
263
277
277
346
463
320
336
797
952
0
682
274
280
682
284
295
298
202
202
181
120
121
121
60
30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000030601211211201812022022982952846822802746820952797336320463346277277263287329296372361461020720340000000000200202030010501020204030405012080603030303040101500303000000
       Other Current Assets 
0
10
10
420
180
50
70
260
260
280
180
320
320
400
280
260
240
200
230
260
200
170
150
80
70
70
70
65
60
30
10
9
10
0
0
0
0
0
12
8
1
3
126
344
231
115
119
5
2
99
112
116
210
212
302
113
250
42
128
71
63
38
23
23
5
24
23
17
4
30
23
23
8
32
30
30
8
0
41
41
2
88
76
76
59
0
28
28
9
28
28
28
410
401
38
38
17
7
7
7
0
7
0
0
0
0
0
0
3
1
1300000070777173838401410282828928280597676882414108303032823233041723245232338637112842250113302212210116112992511911523134412631812000001091030606570707080150170200260230200240260280400320320180280260260705018042010100
   > Long-term Assets 
0
460
280
300
380
310
540
590
590
790
790
770
770
800
850
950
930
900
870
830
820
790
770
700
560
560
470
0
450
390
370
0
350
80
70
0
0
0
68
66
68
74
73
1,643
2,272
2,408
0
2,476
2,844
2,824
2,765
2,734
2,665
2,597
2,719
2,719
494
1,132
514
427
406
380
0
362
293
287
362
275
267
261
236
236
245
273
240
240
236
233
231
231
228
223
221
221
216
215
184
184
182
181
500
500
500
500
222
222
222
222
0
0
0
0
0
0
0
0
0
0
0
0
00000000000022222222222250050050050018118218418421521622122122322823123123323624024027324523623626126727536228729336203804064275141,1324942,7192,7192,5972,6652,7342,7652,8242,8442,47602,4082,2721,64373746866680007080350037039045004705605607007707908208308709009309508508007707707907905905905403103803002804600
       Property Plant Equipment 
0
160
160
160
200
180
400
450
450
620
580
620
620
690
730
820
810
780
740
710
700
670
650
650
430
410
390
364
360
310
290
272
270
0
0
0
0
0
0
0
6
10
10
15
17
95
157
157
385
409
392
376
353
329
496
496
190
197
180
160
144
120
109
109
44
39
35
35
31
27
4
4
4
4
3
3
3
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001111222233344442731353539441091091201441601801971904964963293533763924093851571579517151010600000002702722903103603643904104306506506707007107407808108207306906206205806204504504001802001601601600
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
200
0
0
0
0
0
0
0
0
200
200
200
200
200
200
200
200
200
200
200
200
170
170
170
170
500
500
500
500
222
222
222
222
0
0
0
0
0
0
0
0
0
0
0
0
000000000000222222222222500500500500170170170170200200200200200200200200200200200200000000002002000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
30
30
30
20
20
20
20
20
50
50
30
30
60
60
60
60
60
60
60
60
60
60
60
60
80
80
0
80
80
80
82
80
80
70
0
0
0
68
66
68
64
63
62
60
108
0
114
2,249
2,204
2,162
2,147
2,102
2,057
2,012
2,012
93
65
60
55
51
49
47
47
43
41
47
39
36
34
32
32
41
40
37
37
33
31
29
29
26
22
20
20
16
15
14
14
12
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000111214141516202022262929313337374041323234363947414347474951556065932,0122,0122,0572,1022,1472,1622,2042,24911401086062636468666800070808082808080080806060606060606060606060603030505020202020203030300
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
130
152
84
84
83
83
82
82
82
77
72
0
0
0
68
66
65
64
63
1,628
2,255
2,313
2,319
2,602
2,459
2,415
2,373
2,358
2,313
2,268
2,223
2,179
304
936
335
267
262
260
254
251
249
247
240
237
235
234
232
243
241
269
237
235
233
232
229
227
224
223
221
218
216
215
184
183
182
181
500
500
500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005005005005001811821831842152162182212232242272292322332352372692412432322342352372402472492512542602622673359363042,1792,2232,2682,3132,3582,3732,4152,4592,6022,3192,3132,2551,6286364656668000727782828283838484152130000000000000000000000000
> Total Liabilities 
0
310
320
2,230
2,160
60
130
280
280
480
470
1,210
1,210
1,140
860
1,240
940
1,220
890
1,150
930
850
830
720
730
620
630
776
780
1,140
1,240
1,275
1,270
1,090
1,120
0
0
0
722
722
722
733
267
1,788
2,756
4,109
747
746
1,090
980
1,812
2,762
4,134
5,616
6,536
6,536
6,385
1,628
1,365
1,367
1,585
2,122
846
846
314
426
846
451
668
787
854
854
919
971
1,088
1,088
1,310
1,541
1,705
1,705
1,751
1,773
1,791
1,791
1,892
1,800
1,891
1,891
2,087
2,111
2,140
2,140
2,218
2,105
2,088
2,088
2,156
2,200
2,266
2,266
2,336
2,379
2,436
2,436
2,545
2,601
2,647
2,647
2,784
2,846
2,8462,7842,6472,6472,6012,5452,4362,4362,3792,3362,2662,2662,2002,1562,0882,0882,1052,2182,1402,1402,1112,0871,8911,8911,8001,8921,7911,7911,7731,7511,7051,7051,5411,3101,0881,0889719198548547876684518464263148468462,1221,5851,3671,3651,6286,3856,5366,5365,6164,1342,7621,8129801,0907467474,1092,7561,7882677337227227220001,1201,0901,2701,2751,2401,1407807766306207307208308509301,1508901,2209401,2408601,1401,2101,210470480280280130602,1602,2303203100
   > Total Current Liabilities 
0
160
320
2,230
2,160
60
130
280
280
320
340
1,020
1,020
920
660
1,010
770
1,100
820
1,110
910
850
820
270
280
610
630
776
780
1,140
1,240
1,275
1,270
1,090
1,120
0
0
0
722
722
722
733
267
1,788
2,756
3,712
370
370
711
616
1,762
2,715
4,064
5,563
6,492
6,492
6,341
1,584
1,321
1,323
1,541
2,078
802
802
270
382
802
407
624
743
810
810
875
927
1,044
1,044
1,266
1,497
1,661
1,661
1,710
1,732
1,751
1,751
1,854
1,763
1,855
1,855
2,052
2,076
2,140
2,140
2,218
2,105
2,088
2,088
2,156
2,200
2,266
2,266
2,336
2,379
2,436
2,436
2,545
2,601
2,647
2,647
2,784
2,846
2,8462,7842,6472,6472,6012,5452,4362,4362,3792,3362,2662,2662,2002,1562,0882,0882,1052,2182,1402,1402,0762,0521,8551,8551,7631,8541,7511,7511,7321,7101,6611,6611,4971,2661,0441,0449278758108107436244078023822708028022,0781,5411,3231,3211,5846,3416,4926,4925,5634,0642,7151,7626167113703703,7122,7561,7882677337227227220001,1201,0901,2701,2751,2401,1407807766306102802708208509101,1108201,1007701,0106609201,0201,020340320280280130602,1602,2303201600
       Short-term Debt 
0
0
150
2,000
2,000
0
0
0
0
0
0
0
0
0
0
0
0
460
470
420
430
430
440
0
0
400
400
0
400
450
450
0
400
450
450
0
0
0
453
0
453
448
55
874
1,899
2,929
0
40
110
11
806
1,417
2,086
3,357
3,927
3,927
5,136
342
233
286
385
731
0
98
105
148
168
168
357
394
418
418
514
526
739
739
871
1,063
1,156
1,156
1,199
1,272
1,312
1,312
1,696
1,582
1,657
1,658
1,867
1,906
1,946
1,946
2,064
1,952
2,006
2,006
2,095
2,149
1,539
2,203
2,311
2,366
1,388
2,420
2,528
2,582
0
2,637
2,683
2,829
2,8292,6832,63702,5822,5282,4201,3882,3662,3112,2031,5392,1492,0952,0062,0061,9522,0641,9461,9461,9061,8671,6581,6571,5821,6961,3121,3121,2721,1991,1561,1561,0638717397395265144184183943571681681481059807313852862333425,1363,9273,9273,3572,0861,417806111104002,9291,89987455448453045300045045040004504504000400400004404304304204704600000000000002,0002,00015000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,694
1,210
1,903
4
1,946
2,004
2,064
0
0
2,059
2,095
2,149
1,539
2,257
2,311
2,366
1,554
2,474
1,562
1,565
2,637
2,691
2,683
2,829
2,8292,6832,6912,6371,5651,5622,4741,5542,3662,3112,2571,5392,1492,0952,059002,0642,0041,94641,9031,2101,69400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
120
120
180
150
60
130
200
200
140
190
250
250
300
270
530
380
290
30
300
130
60
120
60
90
40
60
147
150
310
300
388
390
200
230
0
0
0
146
146
146
239
126
808
634
400
245
245
513
378
720
1,099
1,658
1,861
2,206
2,206
1,044
981
749
795
1,146
1,250
438
632
144
187
632
223
265
324
375
375
358
376
285
285
378
407
462
462
474
419
439
405
143
153
197
161
167
171
195
168
149
152
82
56
58
51
48
62
25
13
1,049
16
17
19
10
10
14
16
161410101917161,04913256248515856821521491681951711671611971531434054394194744624624073782852853763583753753242652236321871446324381,2501,1467957499811,0442,2062,2061,8611,6581,099720378513245245400634808126239146146146000230200390388300310150147604090601206013030030290380530270300250250190140200200130601501801201200
       Other Current Liabilities 
0
40
50
50
10
0
0
80
80
180
150
770
770
620
390
480
390
350
320
390
350
360
260
210
190
170
170
225
230
380
490
486
480
440
440
0
0
0
123
576
123
47
85
106
223
382
125
42
112
142
235
199
254
278
301
301
130
344
235
288
387
758
364
170
21
46
170
16
2
24
17
17
2
25
20
20
17
27
43
43
37
41
34
34
15
28
36
36
17
36
27
27
5
0
0
26
4
0
0
665
0
0
0
0
966
0
0
0
87
16
16870009660000665004260052727361736362815343441374343271720202521717242161704621170364758387288235344130301301278254199235142112421253822231068547123576123000440440480486490380230225170170190210260360350390320350390480390620770770150180808000105050400
   > Long-term Liabilities 
0
150
0
0
0
0
0
0
160
160
130
190
190
220
200
230
170
120
70
40
20
10
10
450
450
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
397
0
377
379
364
50
47
69
53
44
44
44
44
44
44
44
44
0
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
44
41
41
39
39
38
38
36
36
36
35
0
0
5
0
0
33
0
0
0
14
0
14
0
0
0
1,195
0
2,647
25
2,846
2,846252,64701,1950001401400033005003536363638383939414144444444444444444444444444444444440444444444444444453694750364379377039700000000000000000001045045010102040701201702302002201901901301601600000001500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
44
0
0
0
0
0
0
0
0
44
44
44
44
44
41
41
41
39
39
38
38
36
34
36
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000353634363838393941414144444444440000000044440000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
397
377
356
335
311
0
0
25
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000092500311335356377397000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
170
40
2,450
1,540
4,770
4,030
3,190
3,190
1,120
1,230
770
770
2,650
2,270
730
520
480
470
710
340
360
680
580
710
310
260
0
-190
-670
-790
0
-890
-980
-1,030
0
0
0
-534
-580
-534
-80
1,055
2,862
1,306
-535
3,566
3,566
3,160
2,500
1,839
871
-590
-2,079
-3,132
-3,132
-4,904
565
-22
-326
-155
-659
456
456
273
198
456
135
-98
-177
-380
-380
-480
-542
-690
-690
-938
-990
-1,215
-1,215
-1,315
-1,377
-1,432
-1,432
-1,614
-1,578
-1,678
-1,678
-1,863
-1,921
-750
-750
-1,017
-993
-1,506
-1,506
-1,716
-1,816
-2,128
-2,128
-2,252
-2,317
-2,381
-2,381
-2,517
-2,580
-2,641
-2,641
-2,779
-2,841
-2,841-2,779-2,641-2,641-2,580-2,517-2,381-2,381-2,317-2,252-2,128-2,128-1,816-1,716-1,506-1,506-993-1,017-750-750-1,921-1,863-1,678-1,678-1,578-1,614-1,432-1,432-1,377-1,315-1,215-1,215-990-938-690-690-542-480-380-380-177-98135456198273456456-659-155-326-22565-4,904-3,132-3,132-2,079-5908711,8392,5003,1603,5663,566-5351,3062,8621,055-80-534-580-534000-1,030-980-8900-790-670-19002603107105806803603407104704805207302,2702,6507707701,2301,1203,1903,1904,0304,7701,5402,450401700
   Common Stock
0
50
50
70
70
90
90
90
90
90
100
100
100
120
130
130
130
140
100
100
100
100
100
100
100
100
100
96
100
100
100
102
100
110
110
0
0
0
139
139
139
165
182
305
306
307
374
374
409
417
417
417
420
424
429
429
435
443
444
444
444
444
444
444
500
503
444
632
499
525
608
608
647
647
647
647
645
696
696
696
657
683
698
698
698
787
787
787
787
787
787
787
796
796
787
787
787
787
787
787
787
787
787
787
787
787
787
787
787
787
787787787787787787787787787787787787787787787787796796787787787787787787787698698698683657696696696645647647647647608608525499632444503500444444444444444444443435429429424420417417417409374374307306305182165139139139000110110100102100100100961001001001001001001001001001401301301301201001001009090909090707050500
   Retained Earnings Total Equity00000-52,251-52,174-52,115-52,051-51,986-51,907-51,8620-51,450-51,360-51,240-50,727-50,751-50,608-50,503-51,623-51,557-51,465-51,373-51,272-51,156-51,048-50,975-50,884-50,774-50,720-50,507-50,282-50,124-49,864-49,68000000000-48,317-48,1780000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-370
-410
-450
-490
-520
-560
-590
-610
-640
-620
-640
-660
0
-680
-680
-700
0
-720
0
0
0
0
0
0
0
0
0
-2
-3
-5
-9
0
-16
-41
-75
-101
-128
-158
-181
-199
-199
-184
-201
-219
-235
-251
-234
0
-247
-151
-156
-247
-160
-161
-165
-29
-29
-30
-30
-30
-30
0
0
0
-32
-32
-32
0
-32
-33
-33
0
-34
-34
-34
0
-34
0
0
0
0
0
0
0
0
0
0
0
52,115
0
-62
0
0
9
9
9900-62052,11500000000000-340-34-34-340-33-33-320-32-32-32000-30-30-30-30-29-29-165-161-160-247-156-151-2470-234-251-235-219-201-184-199-199-181-158-128-101-75-41-160-9-5-3-2000000000-7200-700-680-6800-660-640-620-640-610-590-560-520-490-450-410-370000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,746
47,808
0
0
0
0
0
0
0
0
48,139
48,157
48,375
48,429
48,429
48,582
48,624
48,627
48,678
48,678
48,678
48,740
48,740
48,740
48,740
48,740
48,792
48,792
48,876
48,876
48,876
48,876
9
0
48,876
48,876
48,876
48,876
48,876
48,876
48,876
0
0
0
0
0
0000048,87648,87648,87648,87648,87648,87648,8760948,87648,87648,87648,87648,79248,79248,74048,74048,74048,74048,74048,67848,67848,67848,62748,62448,58248,42948,42948,37548,15748,1390000000047,80847,7460000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
680
680
3,590
3,620
7,980
8,240
8,500
8,500
8,520
9,330
10,410
10,410
11,850
12,210
12,700
13,740
14,640
15,930
17,490
17,850
18,560
19,520
19,970
20,510
20,570
21,030
0
21,060
21,150
21,250
0
21,270
20,570
20,570
0
0
0
20,981
20,981
20,981
22,182
23,613
26,943
27,419
27,539
0
33,707
37,565
38,224
38,810
39,859
40,536
41,112
41,748
41,549
41,661
47,336
47,756
47,778
47,788
48,169
0
47,653
47,746
47,808
47,899
47,903
48,210
48,267
48,159
48,130
48,130
48,130
48,169
48,139
48,375
48,429
48,429
48,429
48,582
48,657
0
48,678
48,678
48,740
0
48,740
48,740
48,748
9
48,800
48,876
48,876
9
48,885
48,885
48,885
9
48,885
48,885
48,885
9
48,885
48,885
48,947
9
48,885
48,876
48,876
48,87648,87648,885948,94748,88548,885948,88548,88548,885948,88548,88548,885948,87648,87648,800948,74848,74048,740048,74048,67848,678048,65748,58248,42948,42948,42948,37548,13948,16948,13048,13048,13048,15948,26748,21047,90347,89947,80847,74647,653048,16947,78847,77847,75647,33641,66141,54941,74841,11240,53639,85938,81038,22437,56533,707027,53927,41926,94323,61322,18220,98120,98120,98100020,57020,57021,270021,25021,15021,060021,03020,57020,51019,97019,52018,56017,85017,49015,93014,64013,74012,70012,21011,85010,41010,4109,3308,5208,5008,5008,2407,9803,6203,5906806800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-43
Operating Income-43-43
 
Operating Expense (+$)
Research Development0
Selling General Administrative43
Selling And Marketing Expenses0
Operating Expense4343
 
Net Interest Income (+$)
Interest Income0
Interest Expense-217
Other Finance Cost-0
Net Interest Income-217
 
Pretax Income (+$)
Operating Income-43
Net Interest Income-217
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-260173
EBIT - interestExpense = -260
-260
-260
Interest Expense217
Earnings Before Interest and Taxes (EBIT)-43-43
Earnings Before Interest and Taxes (EBITDA)-43
 
After tax Income (+$)
Income Before Tax-260
Tax Provision-0
Net Income From Continuing Ops-260-260
Net Income-477
Net Income Applicable To Common Shares-260
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses43
Total Other Income/Expenses Net-217217
 

Technical Analysis of Quantrx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Quantrx. The general trend of Quantrx is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Quantrx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Quantrx Biomedical.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.004 < 0.004 < 0.004.

The bearish price targets are: 0.004 > 0.004 > 0.004.

Tweet this
Quantrx Biomedical Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Quantrx Biomedical. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Quantrx Biomedical Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Quantrx Biomedical. The current macd is -0.00010506.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quantrx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Quantrx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Quantrx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Quantrx Biomedical Daily Moving Average Convergence/Divergence (MACD) ChartQuantrx Biomedical Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Quantrx Biomedical. The current adx is 97.21.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Quantrx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Quantrx Biomedical Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Quantrx Biomedical. The current sar is 0.00462126.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Quantrx Biomedical Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Quantrx Biomedical. The current rsi is 0.14433592. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Quantrx Biomedical Daily Relative Strength Index (RSI) ChartQuantrx Biomedical Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Quantrx Biomedical. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Quantrx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Quantrx Biomedical Daily Stochastic Oscillator ChartQuantrx Biomedical Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Quantrx Biomedical. The current cci is -66.66666667.

Quantrx Biomedical Daily Commodity Channel Index (CCI) ChartQuantrx Biomedical Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Quantrx Biomedical. The current cmo is -99.99657129.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Quantrx Biomedical Daily Chande Momentum Oscillator (CMO) ChartQuantrx Biomedical Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Quantrx Biomedical. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Quantrx Biomedical Daily Williams %R ChartQuantrx Biomedical Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Quantrx Biomedical.

Quantrx Biomedical Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Quantrx Biomedical. The current atr is 0.00001.

Quantrx Biomedical Daily Average True Range (ATR) ChartQuantrx Biomedical Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Quantrx Biomedical. The current obv is -1,640,271.

Quantrx Biomedical Daily On-Balance Volume (OBV) ChartQuantrx Biomedical Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Quantrx Biomedical. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Quantrx Biomedical Daily Money Flow Index (MFI) ChartQuantrx Biomedical Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Quantrx Biomedical.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Quantrx Biomedical Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Quantrx Biomedical based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.144
Ma 20Greater thanMa 500.004
Ma 50Greater thanMa 1000.004
Ma 100Greater thanMa 2000.006
OpenGreater thanClose0.004
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Quantrx with someone you think should read this too:
  • Are you bullish or bearish on Quantrx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Quantrx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Quantrx Biomedical

I send you an email if I find something interesting about Quantrx Biomedical.


Comments

How you think about this?

Leave a comment

Stay informed about Quantrx Biomedical.

Receive notifications about Quantrx Biomedical in your mailbox!